Your browser doesn't support javascript.
loading
The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium.
Bertels, Xander; Mehuys, Els; Boussery, Koen; Lahousse, Lies.
Affiliation
  • Bertels X; Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Mehuys E; Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Boussery K; Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Lahousse L; Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Acta Clin Belg ; 77(5): 815-822, 2022 Oct.
Article in En | MEDLINE | ID: mdl-34569444
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teratogens / Valproic Acid Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Country/Region as subject: Europa Language: En Journal: Acta Clin Belg Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teratogens / Valproic Acid Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Country/Region as subject: Europa Language: En Journal: Acta Clin Belg Year: 2022 Document type: Article Affiliation country: